A Prospective, Mono-Country and Multi-center Study to Observe Safety and Effectiveness of Adalimumab in KoREan Intestinal Behcet's Disease(BD) Patients
Study Identifier
P15-760
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
19 - 99 Years
Protocol Summary
This study evaluates the safety profile and effectiveness of adalimumab in Korean intestinal Behcet's disease (BD) patients in routine clinical practice.
Study Locations
Location
Status
Location
Kyungpook National Univ Hosp /ID# 147937
Daegu, Daegu Gwang Yeogsi, Republic of Korea, 41944
Status
Not applicable
Location
Ajou University Hospital /ID# 147938
Suwon, Gyeonggido, Republic of Korea, 16499
Status
Not applicable
Location
Pusan Nat Univ Yangsan Hosp /ID# 169243
Yangsan, Gyeongsangnam-do, Republic of Korea, 50612
Status
Not applicable
Location
Yonsei University Health System, Severance Hospital /ID# 147932
Seodaemun-gu, Seoul Teugbyeolsi, Republic of Korea, 03722
Status
Not applicable
Location
Samsung Medical Center /ID# 147934
Seoul, Seoul Teugbyeolsi, Republic of Korea, 06351
Status
Not applicable
Location
Cath Univ Seoul St Mary's Hosp /ID# 147936
Seoul, Seoul Teugbyeolsi, Republic of Korea, 06591
Status
Not applicable
Showing {first} - {last} of {total} Results